369 related articles for article (PubMed ID: 19181257)
1. Stereotactic radiotherapy for unilateral orbital lymphoma and orbital pseudo-tumors: a planning study.
Chino K; Tanyi JA; Stea B
Med Dosim; 2009; 34(1):57-62. PubMed ID: 19181257
[TBL] [Abstract][Full Text] [Related]
2. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
3. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
4. [Lens-sparing external beam radiotherapy of periocular lymphomas].
Bajcsay A; Kontra G; Forgács G; Fodor J
Magy Onkol; 2005; 49(3):215-9. PubMed ID: 16249816
[TBL] [Abstract][Full Text] [Related]
5. Optimization of stereotactic radiotherapy treatment delivery technique for base-of-skull meningiomas.
Clark BG; Candish C; Vollans E; Gete E; Lee R; Martin M; Ma R; McKenzie M
Med Dosim; 2008; 33(3):239-47. PubMed ID: 18674690
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
7. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas.
Shaffer R; Nichol AM; Vollans E; Fong M; Nakano S; Moiseenko V; Schmuland M; Ma R; McKenzie M; Otto K
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1177-84. PubMed ID: 19560880
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy for orbital lymphoma.
Zhou P; Ng AK; Silver B; Li S; Hua L; Mauch PM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):866-71. PubMed ID: 15925453
[TBL] [Abstract][Full Text] [Related]
9. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
Goda JS; Le LW; Lapperriere NJ; Millar BA; Payne D; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Simpson R; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e659-66. PubMed ID: 21640514
[TBL] [Abstract][Full Text] [Related]
10. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
Ahmed M; Hansen VN; Harrington KJ; Nutting CM
Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
[TBL] [Abstract][Full Text] [Related]
11. Technical and dosimetric considerations in multi-isocenter intensity modulated radiotherapy for nasopharyngeal carcinoma with small multileaf collimator.
Xiance J; Shixiu W; Jianyi Y; Jinling Y
Med Dosim; 2009; 34(1):9-15. PubMed ID: 19181249
[TBL] [Abstract][Full Text] [Related]
12. Novalis intensity-modulated radiosurgery: methods for pretreatment planning.
Jensen RL; Wendland MM; Chern SS; Shrieve DC
Neurosurgery; 2008 May; 62(5 Suppl):A2-9; discussion A9-10. PubMed ID: 18580777
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck.
Webster GJ; Rowbottom CG; Ho KF; Slevin NJ; Mackay RI
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):617-22. PubMed ID: 18793966
[TBL] [Abstract][Full Text] [Related]
14. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
[TBL] [Abstract][Full Text] [Related]
15. Proton therapy for maxillary sinus carcinoma.
Chera BS; Malyapa R; Louis D; Mendenhall WM; Li Z; Lanza DC; Yeung D; Mendenhall NP
Am J Clin Oncol; 2009 Jun; 32(3):296-303. PubMed ID: 19433966
[TBL] [Abstract][Full Text] [Related]
16. IMRT vs. 3D noncoplanar treatment plans for maxillary sinus tumors: a new tool for quantitative evaluation.
Levin D; Menhel J; Alezra D; Pfeffer R
Med Dosim; 2008; 33(4):275-81. PubMed ID: 18973854
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of graves' ophthalmopathy treated with intensity modulated radiation therapy.
Li YJ; Luo Y; He WM; Li P; Wang F
Radiat Oncol; 2017 Nov; 12(1):171. PubMed ID: 29110673
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison between 3DCRT and IMRT using different multileaf collimators in the treatment of brain tumors.
Ding M; Newman F; Chen C; Stuhr K; Gaspar LE
Med Dosim; 2009; 34(1):1-8. PubMed ID: 19181248
[TBL] [Abstract][Full Text] [Related]
19. Dose escalation in large anterior skull-base tumors by means of IMRT. First experience with the Novalis system.
Ernst-Stecken A; Lambrecht U; Mueller R; Ganslandt O; Sauer R; Grabenbauer G
Strahlenther Onkol; 2006 Mar; 182(3):183-9. PubMed ID: 16520914
[TBL] [Abstract][Full Text] [Related]
20. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
